home / stock / zlab / zlab news


ZLAB News and Press, Zai Lab Limited From 03/25/22

Stock Information

Company Name: Zai Lab Limited
Stock Symbol: ZLAB
Market: NASDAQ
Website: zailaboratory.com

Menu

ZLAB ZLAB Quote ZLAB Short ZLAB News ZLAB Articles ZLAB Message Board
Get ZLAB Alerts

News, Short Squeeze, Breakout and More Instantly...

ZLAB - Which Chinese Stocks Could Get Delisted? 6 Companies to Watch.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today has been a relatively exciting day in the world of stocks. For investors in Chinese stocks, perhaps too exciting. Source: Akarat Phasura / Shutterstock.com A range of Chinese stocks are trading much lower t...

ZLAB - Weibo slumps after SEC adds it to delisting list

Weibo (NASDAQ:WB) shares plunged sharply in mid-day trading on Wednesday after the Securities and Exchange Commission added the Chinese tech company to the list of companies on its Holding Foreign Companies Accountable Act. Shares of Weibo, which is akin to Twitter, fell more than 3...

ZLAB - Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022

SHANGHAI and SAN FRANCISCO, and CAMBRIDGE, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that, due to the public health impact of the coronavirus (COVID...

ZLAB - Alibaba And Chinese Tech Stocks: Record $25B Stock Buyback Is The Buy Signal You Need

Alibaba announced a new massive $25B stock buyback program. It replaced its previous $15B authorization. After last week's massive capitulation in Chinese tech stocks, China has also been following up with policy adjustments. We discuss why we revised our rating on BABA stock to S...

ZLAB - Zai Lab posts late-stage data for niraparib as maintenance therapy in ovarian cancer

On Monday, the Chinese biotech, Zai Lab (NASDAQ:ZLAB), announced the results from its Phase 3 PRIME study for ZEJULA (niraparib) as maintenance therapy in a group of patients with ovarian cancer. The placebo-controlled study involved 384 Chinese patients with advanced ovarian cancer who showe...

ZLAB - Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting

PRIME study demonstrates that niraparib treatment had a statistically significant and clinically meaningful improvement in progression-free survival in the overall study population regardless of biomarker status when compared to placebo The primary endpoint of the t...

ZLAB - Is NIO Still Investable? Depends On Whether You Can Stomach The Risks

It has been a turbulent ride for NIO this year, especially over the past week as Chinese stocks experienced both the worst sell-off and biggest jump since 2008. Earlier this week, NIO posted sharp multi-day plunges following renewed concerns over delisting and regulatory risks. Th...

ZLAB - Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2021 Update

Halvorsen's 13F portfolio value decreased from $36.04B to $34.49B this quarter. The number of positions increased from 96 to 107. Viking Global added Twilio, Workday, and Aon plc while dropping Fidelity National Information Services and Snowflake. The top three positions are Ginkg...

ZLAB - Zai Lab, 111 top healthcare gainers; Talis Biomedical, Incannex lead losers' pack

Gainers: Zai Lab (NASDAQ:ZLAB) +27%. 111 (NASDAQ:YI) +26%. LianBio (NASDAQ:LIAN) +22%. BeiGene BGNE +20%. Palisade Bio PALI +10%. Losers: Talis Biomedical (NASDAQ:TLIS) -42%. Incannex Healthcare (NASDAQ:IXHL) -32%. NLS Pharmaceutics NLSP&...

ZLAB - Chinese Stocks: The Perfect Storm Of COVID-19 Lockdowns, Delisting And Russia

Chinese stocks have experienced the worst sell-off since the 2008 global financial crisis. The culmination of geopolitical and COVID-19 risks has created a perfect storm for investors. We discuss how investors should position themselves. For further details see: Chinese ...

Previous 10 Next 10